Metastatic human rhabdomyosarcoma: Molecular, cellular and cytogenetic analysis of a novel cellular model

T. Kalebic, J. G. Judde, M. Velez-Yanguas, T. Knutsen, Lee J. Helman

Research output: Contribution to journalArticle

Abstract

A new human metastatic rhabdomyosarcoma (RMS) model was established and analyzed for a number of biologic, cytogenetic and molecular parameters. Consistent with previous studies, the metastatic capacity of different RMS cell variants did not correlate with their tumorigenic or proliferative capacities. Interestingly, a highly metastatic variant was diploid, while a nonmetastatic variant was tetraploid, which parallels previous clinical observations. Genes whose expression had been found to be associated with either low-or high-metastatic capacity in carcinoma or melanoma did not show a similar association with different metastatic variants of RMS, derived from a mesenchymal tumor. We also found, in transient reporter gene assays, that several promoters had higher transcriptional activity in highly metastatic than in nonmetastatic RMS cell variants. This novel human RMS metastatic model may be instrumental for a better understanding of the regulatory pathways that control the metastatic phenotype of tumors of mesenchymal origin.

Original languageEnglish (US)
Pages (from-to)83-96
Number of pages14
JournalInvasion and Metastasis
Volume16
Issue number2
StatePublished - 1996
Externally publishedYes

Fingerprint

Rhabdomyosarcoma
Cytogenetic Analysis
Tetraploidy
Diploidy
Reporter Genes
Cytogenetics
Melanoma
Neoplasms
Carcinoma
Phenotype
Gene Expression

Keywords

  • Rhabdomyosarcoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Kalebic, T., Judde, J. G., Velez-Yanguas, M., Knutsen, T., & Helman, L. J. (1996). Metastatic human rhabdomyosarcoma: Molecular, cellular and cytogenetic analysis of a novel cellular model. Invasion and Metastasis, 16(2), 83-96.

Metastatic human rhabdomyosarcoma : Molecular, cellular and cytogenetic analysis of a novel cellular model. / Kalebic, T.; Judde, J. G.; Velez-Yanguas, M.; Knutsen, T.; Helman, Lee J.

In: Invasion and Metastasis, Vol. 16, No. 2, 1996, p. 83-96.

Research output: Contribution to journalArticle

Kalebic, T, Judde, JG, Velez-Yanguas, M, Knutsen, T & Helman, LJ 1996, 'Metastatic human rhabdomyosarcoma: Molecular, cellular and cytogenetic analysis of a novel cellular model', Invasion and Metastasis, vol. 16, no. 2, pp. 83-96.
Kalebic, T. ; Judde, J. G. ; Velez-Yanguas, M. ; Knutsen, T. ; Helman, Lee J. / Metastatic human rhabdomyosarcoma : Molecular, cellular and cytogenetic analysis of a novel cellular model. In: Invasion and Metastasis. 1996 ; Vol. 16, No. 2. pp. 83-96.
@article{b14cfcdd9c08451f8f72f3e0483d46e9,
title = "Metastatic human rhabdomyosarcoma: Molecular, cellular and cytogenetic analysis of a novel cellular model",
abstract = "A new human metastatic rhabdomyosarcoma (RMS) model was established and analyzed for a number of biologic, cytogenetic and molecular parameters. Consistent with previous studies, the metastatic capacity of different RMS cell variants did not correlate with their tumorigenic or proliferative capacities. Interestingly, a highly metastatic variant was diploid, while a nonmetastatic variant was tetraploid, which parallels previous clinical observations. Genes whose expression had been found to be associated with either low-or high-metastatic capacity in carcinoma or melanoma did not show a similar association with different metastatic variants of RMS, derived from a mesenchymal tumor. We also found, in transient reporter gene assays, that several promoters had higher transcriptional activity in highly metastatic than in nonmetastatic RMS cell variants. This novel human RMS metastatic model may be instrumental for a better understanding of the regulatory pathways that control the metastatic phenotype of tumors of mesenchymal origin.",
keywords = "Rhabdomyosarcoma",
author = "T. Kalebic and Judde, {J. G.} and M. Velez-Yanguas and T. Knutsen and Helman, {Lee J.}",
year = "1996",
language = "English (US)",
volume = "16",
pages = "83--96",
journal = "Invasion and Metastasis",
issn = "0251-1789",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Metastatic human rhabdomyosarcoma

T2 - Molecular, cellular and cytogenetic analysis of a novel cellular model

AU - Kalebic, T.

AU - Judde, J. G.

AU - Velez-Yanguas, M.

AU - Knutsen, T.

AU - Helman, Lee J.

PY - 1996

Y1 - 1996

N2 - A new human metastatic rhabdomyosarcoma (RMS) model was established and analyzed for a number of biologic, cytogenetic and molecular parameters. Consistent with previous studies, the metastatic capacity of different RMS cell variants did not correlate with their tumorigenic or proliferative capacities. Interestingly, a highly metastatic variant was diploid, while a nonmetastatic variant was tetraploid, which parallels previous clinical observations. Genes whose expression had been found to be associated with either low-or high-metastatic capacity in carcinoma or melanoma did not show a similar association with different metastatic variants of RMS, derived from a mesenchymal tumor. We also found, in transient reporter gene assays, that several promoters had higher transcriptional activity in highly metastatic than in nonmetastatic RMS cell variants. This novel human RMS metastatic model may be instrumental for a better understanding of the regulatory pathways that control the metastatic phenotype of tumors of mesenchymal origin.

AB - A new human metastatic rhabdomyosarcoma (RMS) model was established and analyzed for a number of biologic, cytogenetic and molecular parameters. Consistent with previous studies, the metastatic capacity of different RMS cell variants did not correlate with their tumorigenic or proliferative capacities. Interestingly, a highly metastatic variant was diploid, while a nonmetastatic variant was tetraploid, which parallels previous clinical observations. Genes whose expression had been found to be associated with either low-or high-metastatic capacity in carcinoma or melanoma did not show a similar association with different metastatic variants of RMS, derived from a mesenchymal tumor. We also found, in transient reporter gene assays, that several promoters had higher transcriptional activity in highly metastatic than in nonmetastatic RMS cell variants. This novel human RMS metastatic model may be instrumental for a better understanding of the regulatory pathways that control the metastatic phenotype of tumors of mesenchymal origin.

KW - Rhabdomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0030477145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030477145&partnerID=8YFLogxK

M3 - Article

C2 - 9030243

AN - SCOPUS:0030477145

VL - 16

SP - 83

EP - 96

JO - Invasion and Metastasis

JF - Invasion and Metastasis

SN - 0251-1789

IS - 2

ER -